MedPath

Advanced MRI Applications for Mild Traumatic Brain Injury

Not Applicable
Terminated
Conditions
Mild Traumatic Brain Injury
Traumatic Brain Injury
Interventions
Device: MRI
Registration Number
NCT02070588
Lead Sponsor
GE Healthcare
Brief Summary

This feasibility study is being conducted to determine potential associations between a broad range of clinical neurological symptoms and magnetic resonance images (MRI), data, and clinical findings involved in mild traumatic brain injury (mTBI).

These associations will be examined over the acute and sub-acute period (approximately 3 months) following injury to provide information useful for optimization of MR pulse sequences for mTBI applications.

Correlations exist over the sub-acute period in clinical neurological and MR data (images, image reads, and RAW data), which may indicate temporal evolution patterns. The intent of this study is to broadly generate potential biomarkers of temporal evolution of mTBI detectable in MR images and data ("MR mTBI biomarkers").

Detailed Description

This hypothesis-generating feasibility study is being conducted to determine potential associations between a broad range of clinical neurological symptoms and MR images, data, and clinical findings involved in mild traumatic brain injury (mTBI). These associations will be examined over the acute and sub-acute period (approximately 3 months) following injury to provide information useful for optimization of MR pulse sequences for mTBI applications.

The intent of this study is to broadly generate a range of potential mTBI biomarkers detectable using investigational MR pulse sequence technologies. Feasibility data attained in this study may be used for engineering program decision-making and in support of future scientific assessment, engineering development, published research databases or registries mTBI data and images, and other purposes determined by the Sponsor. The results of this study are not intended for use in regulatory submissions.

Subjects will be examined on commercially available MR scanners using investigational or standard of care MR coils and a series of investigational MR Pulse Sequence sets (Application Packs). Each Application Pack will consist of a predetermined sequence of investigational pulse sequences (IPSs) optimized by GE Healthcare (GEHC) for mTBI. IPSs will be administered in a predetermined order as part of each Application Pack.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
112
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Experimental: Diagnostic mTBIMRIMRI Diagnostic of subjects with mild Tramatic Brain Injury (mTBI)
Experimental: Diagnostic Non mTBIMRIMRI Diagnostic of Non injured subjects that are closely matched to mTBI
Primary Outcome Measures
NameTimeMethod
mTBI Progression Indicated by Clinical Neurological Characteristics, MRI Images, and Quantitative MRI Data From Novel SoftwarePer-patient 1 to 3 months, until dataset completion 1 yr

To determine associations between clinical neurological data, MR images, quantitative data from novel software post-processing (sponsor developed software including volumetry, Resting State \[RS\] functional magnetic resonance imaging \[fMRI\], kurtosis).

Secondary Outcome Measures
NameTimeMethod
Subject DemographicsPer-patient 1 to 3 months, until dataset completion 1 yr

To comprehensively collect subject information (i.e. baseline health data, demographics, socioeconomics, injury presentation, post-injury status, and injury type, place, and cause) for mTBI subjects in context of MRI data.

Operator Set MRI ParametersPer-patient 1 to 3 months, until dataset completion 1 yr

To record operator-adjusted parameters of the novel software on the MRI system

Trial Locations

Locations (1)

Hospital for Special Surgery

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath